IFABOND (VITALITEC) SURGICAL GLUE IN LAPAROSCOPIC SLEEVE GASTRECTOMY- AN INITIAL EXPERIENCE AND COST EFFECTIVENESS ANALYSIS
Author(s)
Bourel G, Mercier G, Nocca D, Loureiro M, Georgescu V, Lefebvre P, Fabre JM
CHU Montpellier, Montpellier, France
Presentation Documents
METHODS: A prospective, observational and comparative before-after study was conducted. All consecutive patients undergoing LSG at Montpellier University Hospital in 2011 and 2012 were included and treated according to two groups: standard stapling (n=99, Group 1) and surgical glue reinforcement (n=94, Group 2). Clinical and economic outcomes were measured after 6 months. RESULTS: The duration of intervention was significantly shorter in Group 2 (68 vs. 82 minutes, p=0.001). There was no significant difference regarding complications but leaks in Group 1 were more severe. Group 2 was also associated with a reduced initial length of stay (4.8 vs. 5.2 days, p=0.01). Six-month readmissions, and total length of stay was also shorter in group 2 (5.5 vs. 6.1 days, p=0.003). Surgical glue use was associated with a significant reduction in the initial inpatient cost (5488 vs. 6152 €, p=0.005) and in the 6-month total inpatient cost including readmissions (6006 vs. 6754 €, p=0.005). The incremental cost of glue to avoid a severe complication was -5446.33 € (95CI: -8202.01; -2690.66).
CONCLUSIONS: IFABOND® surgical glue might be a safe and cost-effective intervention in laparoscopic sleeve gastrectomy.
Conference/Value in Health Info
Value in Health, Vol. 20, No. 5 (May 2017)
Code
PSY69
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Diabetes/Endocrine/Metabolic Disorders